This document provides an overview of testicular tumours, including:
- Germ cell tumors (GCTs) comprise 95% of testicular cancers and are categorized as seminomas or non-seminomas.
- Risk factors include cryptorchidism, family history, prior testicular cancer, and intratubular germ cell neoplasia.
- The World Health Organization classifies testicular tumors and includes categories such as seminoma, embryonal carcinoma, teratoma, and sex cord-stromal tumors.
- Extragonadal GCTs can occur in sites like the mediastinum and retroperitoneum.
This presentation demonstrates the current paradigm in the treatment of desmoid tumors. As the management is shifting from surgical approach to medical management.
This presentation demonstrates the current paradigm in the treatment of desmoid tumors. As the management is shifting from surgical approach to medical management.
02 Presentations Ii Vs (14 4 Mb) (3 30 08)vshidham
Part II of Four part symposium: “Diagnostic Cytopathology of Serous Effusion” on April 19, 2007 at Neenah, WI, USA
(2008 Wisconsin Society of Cytology, 40th Anniversary)
non-skeletal mesodermal tissues: adipose tissue, fibrous tissue, muscle, blood vessels and peripheral nerves (despite neuroectodermal origin)
benign, malignant and intermediate (low-grade malignant – locally aggressive, can recur, no metastatic potential)
originate from primitive mesenchymal stem cells
classification according to differentiation lines (e.g. liposarcoma is not a tumor arising from adipose tissue but exhibiting lipoblastic differentiation)
Histopathological Grossing of Kidney Tumors with the common gross differentials encountered,
reference - TATA memorial grossing techniques , Rosai and ackerman surgical pathology , Fletcher , Springer histopathology Specimen
Hints about tuberculosis , Epididymis anatomy and functions, Epididymis infection with TB, Incidence, Clinical picture and complications of it, Hints about the diagnosis and treatment
Presented in the department of Urology, Sohag school of medicine
02 Presentations Ii Vs (14 4 Mb) (3 30 08)vshidham
Part II of Four part symposium: “Diagnostic Cytopathology of Serous Effusion” on April 19, 2007 at Neenah, WI, USA
(2008 Wisconsin Society of Cytology, 40th Anniversary)
non-skeletal mesodermal tissues: adipose tissue, fibrous tissue, muscle, blood vessels and peripheral nerves (despite neuroectodermal origin)
benign, malignant and intermediate (low-grade malignant – locally aggressive, can recur, no metastatic potential)
originate from primitive mesenchymal stem cells
classification according to differentiation lines (e.g. liposarcoma is not a tumor arising from adipose tissue but exhibiting lipoblastic differentiation)
Histopathological Grossing of Kidney Tumors with the common gross differentials encountered,
reference - TATA memorial grossing techniques , Rosai and ackerman surgical pathology , Fletcher , Springer histopathology Specimen
Hints about tuberculosis , Epididymis anatomy and functions, Epididymis infection with TB, Incidence, Clinical picture and complications of it, Hints about the diagnosis and treatment
Presented in the department of Urology, Sohag school of medicine
Presentation about the the second most common type of ovarian tumors which have a very unique property of being similar to the testicular germ cell tumors.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Moderators:
Professors:
• Prof. Dr.G. Sivasankar,M.S., M.Ch.,
• Prof. Dr.A. Senthilvel,M.S., M.Ch.,
Asst Professors:
• Dr.J. Sivabalan,M.S., M.Ch.,
• Dr. R. Bhargavi,M.S., M.Ch.,
• Dr.S. Raju, M.S., M.Ch.,
• Dr. K. Muthurathinam,M.S., M.Ch.,
• Dr. D.Tamilselvan,M.S., M.Ch.,
• Dr. K. Senthilkumar,M.S., M.Ch.
Dept of Urology, GRH and KMC,Chennai. 2
3. • Neoplasms of the testis comprise a morphologically and
clinically diverse group of tumors
• In United States
Testicular cancer - most common malignancy among men
aged 20 to 40 years
• Rates are highest in Scandinavia, Germany, Switzerland, and
New Zealand
Intermediate - United States and Great Britain
Lowest - Africa and Asia
3
Dept of Urology, GRH and KMC,Chennai.
4. • Germ cell tumors (GCTs) - 95%
GCTs - broadly categorized
Seminoma
Nonseminoma (NSGCT)
• 90% of GCTs - Arise in the testis
• 2% to 5% - Extragonadal
Retroperitoneum and mediastinum - Most common sites
• Incidence of bilateral GCT
- approximately 2%
4
Dept of Urology, GRH and KMC,Chennai.
5. Risk Factors
• Well -established risk factors
- cryptorchidism
- family history of testicular cancer
- personal history of testicular cancer
- intratubular germ cell neoplasia (ITGCN).
Infertile men - have a higher incidence of testicular
cancer.
5
Dept of Urology, GRH and KMC,Chennai.
6. • Males with cryptorchidism - four to six times more
likely to be diagnosed with testicular cancer
• Meta-analysis - cryptorchidism studies reported that
contralateral descended testis
- slightly increased risk
• Men with first-degree relative with testicular cancer
have - increased risk
6
Dept of Urology, GRH and KMC,Chennai.
7. World Health Organization
Classification of Testicular Tumors
Germ Cell Tumors
Precursor lesions—intratubular malignantgerm cells
(carcinoma In situ)
Seminoma
Variant—seminoma with syncytiotrophoblastic cells
Spermatocytic seminoma
Variant—spermatocytic seminoma with sarcoma
Embryonal carcinoma
Yolk sac tumor
Polyembryoma 7
Dept of Urology, GRH and KMC,Chennai.
8. Trophoblastic tumors
Choriocarcinoma
Choriocarcinoma with other cell types
Placental site trophoblastic tumor
Teratoma
Mature teratoma
Dermoid cyst
Immature teratoma
Teratoma with malignant areas 8
Dept of Urology, GRH and KMC,Chennai.
9. Sex Cord/Gonadal Stromal
Tumors
Pure forms
Leydig cell tumor
Sertoli cell tumor
Large-cell calcifying Sertoli cell tumor
Lipid-rich Sertoli cell tumor
Granulosa cell tumor
Adult-type granulosa cell tumor
Juvenile-type granulosa cell tumor
Tumors of thecoma/fibroma group
Incompletely differentiated sex cord/gonadal stromal tumors
Mixed forms 9
Dept of Urology, GRH and KMC,Chennai.
10. Tumors Containing Both Germ Cell and Sex Cord/Gonadal Stromal
Elements
Gonadoblastoma
Mixed germ cell–sex cord/gonadal stromal tumors, unclassified
Miscellaneous Tumors
Carcinoid tumor
Tumors of ovarian epithelial types
Lymphoid and Hematopoietic Tumors
Lymphoma
Plasmacytoma
Leukemia
10
Dept of Urology, GRH and KMC,Chennai.
11. Tumors of Collecting Ducts and Rete
Adenoma
Carcinoma
Tumors of the Tunica, Epididymis, Spermatic Cord, Supporting Structures, and
Appendices
Adenomatoid tumor
Mesothelioma
Benign
Malignant
Adenoma
Carcinoma
Melanotic neuroectodermal
Desmoplastic small round cell tumor
11
Dept of Urology, GRH and KMC,Chennai.
12. Soft Tissue Tumors
Unclassified Tumors
Secondary Tumors
Tumor-like Lesions
o Nodules of immature tubules
o Testicular lesions of adrenogenital syndrome
o Testicular lesions of androgen-insensitivity syndrome
o Nodular precocious maturation
o Specific orchitis
o Nonspecific orchitis
o Granulomatous orchitis
o Malakoplakia
o Adrenal cortical rest
o Fibromatous peritonitis
o Funiculitis
12
Dept of Urology, GRH and KMC,Chennai.
13. Intratubular Germ Cell Neoplasia
• All adult invasive GCTs arise from ITGCN except
spermatocytic seminoma
• ITGCN - undifferentiated germ cells that have the
appearance of seminoma
• Located basally within the seminiferous tubules
• Tubule - shows decreased or absent spermatogenesis, and
normal constituents are replaced by ITGCN.
• ITGCN - much less frequent in pediatric GCTs
13
Dept of Urology, GRH and KMC,Chennai.
14. • Incidence of CIS in the
male population - 0.8%.
• Testicular CIS develops
from fetal gonocytes
• characterized
histologically by
seminiferous tubules
containing only Sertoli
cells and malignant germ
cells.
14
Dept of Urology, GRH and KMC,Chennai.
15. Seminoma
• Most common type - GCT( 45% )
• Occur - fourth or fifth decade of life
• TYPES
Classic seminoma
Anaplastic seminoma
Atypical seminoma
Spermatocytic seminoma
• Grossly, seminoma - soft tan to white diffuse or multinodular
mass Necrosis may be present but is usually focal
15
Dept of Urology, GRH and KMC,Chennai.
16. • Histologically - consist of a sheetlike arrangement of cells
with polygonal nuclei and clear cytoplasm, with the cells
divided into nests by fibrovascular septa that contain
lymphocytes
• Syncytiotrophoblasts - which stain positive for human
choriogonadotropin
• Lymphocytic infiltrates and granulomatous reactions are
often seen
16
Dept of Urology, GRH and KMC,Chennai.
17. • Large cell sheets with
abundant cytoplasm
• Round hyperchromatic
nuclei with abundant
nucleoli
• Lymphocytic infiltrate
• Trophoblastic giant cells
that produce hCG – 10%
17
Dept of Urology, GRH and KMC,Chennai.
18. • Immunohistochemical staining typically
Negative for CD30
Positive for CD117
Strongly positive for placental alkaline
phosphatase (PLAP).
18
Dept of Urology, GRH and KMC,Chennai.
19. SpermatocyticSeminoma
• Rare & accounts for less than 1% of GCTs.
• Variant of seminoma - represents a distinct
clinicopathologic entity from other GCTs.
• Peak incidence - sixth decade of life
• Does not arise from ITGCN
• Not associated with a history of cryptorchidism or
bilaterality,
• Does not express PLAP and does not occur as part of
mixed GCTs
. 19
Dept of Urology, GRH and KMC,Chennai.
20. Histopathologically
• Nuclei are round, minimal lymphocytic filtration is
present
• Three distinct cell types are present
• Small lymphocyte-like cells, medium-sized cells with
dense eosinophilic cytoplasm and a round nucleus, and
large mononucleated or multinucleated cells
• Benign tumor , always cured with orchiectomy
20
Dept of Urology, GRH and KMC,Chennai.
21. NSGCT
• 55% of GCTs
• Third decade of life
• Most tumor types are mixed including
seminoma
• All have equal prognosis
21
Dept of Urology, GRH and KMC,Chennai.
22. Embryonal Carcinoma
• Consists of undifferentiated
malignant cells resembling
primitive epithelial cells from
early-stage embryos with crowded
pleomorphic nuclei
• Grossly - tan to yellow neoplasm
that often exhibits large areas of
hemorrhage and necrosis.
22
Dept of Urology, GRH and KMC,Chennai.
23. Microscopic appearance
• Grow in solid sheets or in papillary, glandular-alveolar, or
tubular patterns
• Is an aggressive tumor associated with a high rate of
metastasis, with normal serum tumor markers.
• Increased risk of occult metastases
• Typically stains - AE1/AE3, PLAP, and OCT3/4 and does
not stain for c-KIT.
23
Dept of Urology, GRH and KMC,Chennai.
24. Choriocarcinoma
• Rare and aggressive tumor
• Presents as elevated serum hCG levels and
disseminated disease
• Choriocarcinoma commonly spreads by
hematogenous routes
common sites of metastases - lungs and brain, but eye
and skin metastases have also reported
24
Dept of Urology, GRH and KMC,Chennai.
25. Microscopically
• Tumor - composed of
syncytiotrophoblasts and
cytotrophoblasts,
stain positively for hCG
• Areas of hemorrhage and
necrosis - prominent.
25
Dept of Urology, GRH and KMC,Chennai.
26. Yolk SacTumor
• Endodermal sinus tumors
small fraction of adult-type
GCTs
• More common in
mediastinal and pediatric
GCTs.
• Mimics yolk sac of the embryo
• Produces alpha feto protein
26
Dept of Urology, GRH and KMC,Chennai.
27. • Consists reticular network of medium-sized cuboidal cells
with cytoplasmic and extracytoplasmic eosinophilic,
hyaline-like globules
• Hyaline globules - characteristic feature (84% of cases).
• Grow in a glandular, papillary, or microcystic pattern.
• A characteristic feature - Schiller-Duval body, which
resembles endodermal sinuses,
• Yolk sac tumors almost always produce AFP but not
hCG.
27
Dept of Urology, GRH and KMC,Chennai.
28. Teratoma
• Tumors contain well-differentiated or incompletely differentiated
elements of at least two of the three germ cell layers of endoderm,
mesoderm, and ectoderm.
• Derived from a pluripotent malignant precursor
• Characteristically all components are intermixed.
• Well-differentiated tumors - Mature teratomas,
• Whereas incompletely differentiated - called Immature
teratomas.
28
Dept of Urology, GRH and KMC,Chennai.
29. • Mature teratomas include elements
of mature bone, cartilage, teeth,
hair, and squamous epithelium
• Gross appearance - teratoma
depends largely on the elements
within it,
most tumors having solid and
cystic areas.
29
Dept of Urology, GRH and KMC,Chennai.
30. • Teratoma - resistant to chemotherapy
• Teratomas may grow uncontrollably, invade
surrounding structures, and become unresectable
• On rare occasions, teratoma may transform into a
somatic malignancy such as rhabdomyosarcoma,
adenocarcinoma, or primitive neuroectodermal
tumor.
30
Dept of Urology, GRH and KMC,Chennai.
31. • “Teratoma with malignant transformation.”
• Highly aggressive, resistant to conventional
chemotherapy, and associated with a poor
prognosis.
• Teratomas - associated with normal serum tumor
markers, but they may cause mildly elevated serum
AFP levels
31
Dept of Urology, GRH and KMC,Chennai.
32. EXTRA GONADAL GERM CELLTUMORS
• Primary tumors of
extragonadal origin are
rare
• 3-5% of all GCTs are
extragonadal
• Most common sites:
1. Mediastinum
2. Retroperitoneum
3. Sacrococcygeal region
4. Pineal gland
32
Dept of Urology, GRH and KMC,Chennai.
33. EXTRA GONADAL GERM CELLTUMORS
• Histologically all germ cell
types are represented
• Pure seminoma accounting
for nearly half
• May reach large size with
no or relatively few
symptoms
• High potential for local
invasion and distant
metastasis 33
Dept of Urology, GRH and KMC,Chennai.
35. Leydig CellTumors
• Most common of the sex cord/stromal tumors.
• No association with cryptorchidism.
• Occur in adult males between age 20 and 60 years,
• Painless testicular mass - most common
presentation , frequently with feminizing
characteristics (gynecomastia, impotence, and
decreased libido).
35
Dept of Urology, GRH and KMC,Chennai.
36. • Ninety percent of these tumors -benign
10% are malignant
• Macroscopic - usually small, yellow to brown, well
circumscribed, and without areas of necrosis of hemorrhage.
• Histologically, tumors consist of uniform polygonal cells
with round nuclei.
Reinke crystals - present ( 25% to 40%) appear as densely
eosinophilic needle-like or rhomboid structures within the
cytoplasm.
36
Dept of Urology, GRH and KMC,Chennai.
37. • Most frequent metastatic sites -
Retroperitoneum and lung.
• Metastatic Leydig cell tumors - resistant to
chemotherapy and radiation therapy
• Radical inguinal orchiectomy
- Treatment of choice
37
Dept of Urology, GRH and KMC,Chennai.
38. Sertoli CellTumor
• Comprise less than 1% of testicular neoplasms.
• Can occur in any age group
• No association with cryptorchidism.
• Wel l circumscribed and yellow-white or tan, with
uniform consistency.
• Microscopically - tumors contain epithelial elements
resembling Sertoli cells with varying amounts of
stroma organized into tubules.
38
Dept of Urology, GRH and KMC,Chennai.
39. • Ninety percent of tumors - benign, and 10% are
malignant.
• Treatment - radical inguinal orchiectomy
• RPLND - considered if the suspicion of malignancy is
high or if retroperitoneal adenopathy exists.
• Radiation therapy and chemotherapy are ineffective.
39
Dept of Urology, GRH and KMC,Chennai.
40. Granulosa CellTumors
• Exceedingly rare and resemble adult-type
granulosa cell tumors of the ovary
• Gynecomastia and increased estrogen secretion
are common
• Radical inguinal orchiectomy - curative
because these tumors appear to have limited
metastatic potential.
40
Dept of Urology, GRH and KMC,Chennai.
41. Gonadoblastoma
• Mixed germ cell/sex cord/stromal tumor composed of
seminoma-like germ cells and sex cord cells showing
Sertoli differentiation.
• Occur almost with dysgenic gonads and intersex
syndromes.
• Eighty percent of affected individuals are phenotypic
females, usually presenting with primary amenorrhea
41
Dept of Urology, GRH and KMC,Chennai.
42. • Remainder - phenotypic males, present with
cryptorchidism , hypospadias
• One third of cases - bilateral
• Gonadoblastomas do not metastasize
• Bilateral orchiectomy - required because of
the risk of bilateral tumors.
42
Dept of Urology, GRH and KMC,Chennai.
43. MiscellaneousTesticular Neoplasms
• Adenocarcinoma of the Rete Testis
- Rare but highly malignant neoplasm arising from the collecting
system of the testis.
- Usual presentation is a painless testicular mass with hydrocele.
- More than 50% of patients present with metastatic disease
- RPLND - curative with limited retroperitoneal lymph node
metastasis.
- Chemotherapy and radiation therapy - ineffective.
43
Dept of Urology, GRH and KMC,Chennai.
44. • Primary testicular non-Hodgkin lymphoma - rare
tumor and 1% to 2% of all cases of lymphoma.
• Most commonly - lymphoma involves the testis
through dissemination from extratesticular sites
• Eighty-five percent of cases occur in men older than
age 60.
• SecondaryTumors of theTestis
Lymphoma
44
Dept of Urology, GRH and KMC,Chennai.
45. • Non-Hodgkin lymphoma - most common testicular
neoplasm
• Bilateral testicular involvement - 35% of cases
• Usually presents as painless testicular mass in an older
man. 25% of men have systemic symptoms (fever, night
sweats, weight loss).
• Treatment - radical inguinal orchiectomy.With
chemotherapy
45
Dept of Urology, GRH and KMC,Chennai.
46. Metastases
• Metastases to the testis - rare
• Usually associated with diffuse metastatic disease.
• Bilateral involvement occurs in 15% of patients.
• Most common primary lesions - prostate cancer, lung
cancer, melanoma, colon cancer, and kidney cancer
• Treatment - largely dictated by the primary tumor,
orchiectomy may be considered for palliative reasons.
46
Dept of Urology, GRH and KMC,Chennai.
47. TUMORS OF THE TESTICULAR ADNEXA
AdenomatoidTumor
• Most common paratesticular tumor
• Commonly involving = epididymis
• Most common presentation - small , painless
paratesticular mass ,third or fourth decade
• Microscopic examination -composed of epithelial-like
cells that contain vacuoles and fibrous stroma
• Tumors - benign and managed by inguinal exploration
and surgical excision..
47
Dept of Urology, GRH and KMC,Chennai.
48. Cystadenoma
• Cystadenoma of the epididymis -- corresponds to benign epithelial
hyperplasia.
• Lesions - usually multicystic, the walls of which are studded with
nodules of epithelial cells arranged in a glandular or papillary
configuration.
• One third of cases occur in patients with von Hippel-Lindau
syndrome.
• Lesions - usually small and painless and are detected on routine
examination in a young adult.
48
Dept of Urology, GRH and KMC,Chennai.
49. Mesothelioma
• Paratesticular mesothelioma arises from the tunica
vaginalis
• Presents as a painless scrotal mass in association with a
hydrocele
• Occur in older adults but may be encountered in any age
group.
• Both benign and malignant mesothelioma have been
described, with the distinction based on atypia, mitotic
activity, and invasion
49
Dept of Urology, GRH and KMC,Chennai.
50. • Malignant cases - associated with asbestos
exposure.
• Treatment - Radical inguinal orchiectomy
• RPLND - considered in patients with malignant
tumors withoutwidespread metastaticdisease.
50
Dept of Urology, GRH and KMC,Chennai.
51. Sarcoma
• Sarcomas of the spermatic cord, epididymis,and testis - most common
genitourinarysarcomas in adults.
• Liposarcoma - most common histologic subtype in adults, followed
by rhabdomyosarcoma,leiomyoma,malignant fibrous histiocytoma, and
fibrosarcoma
• Embryonal rhabdomyosarcoma - most common histologic subtype
in men younger than age 30
• Present as a painless, palpablemass, and most are large (>5 cm)
• Ultrasonography - demonstratea solid mass, although it cannot
distinguish between benign and malignantpathology
51
Dept of Urology, GRH and KMC,Chennai.
52. • Sarcomas - inguinal approach with wide excision of the
spermatic cord and testis with high ligation.
• Liposarcomas rarely metastasize but tend to recur
locally
• Postoperative radiation therapy - considered for
tumors or in those in whom the adequacy of local
excision is in doubt
• Systemic chemotherapy should be given to patients with
evidence of retroperitoneal or distant metastases.
52
Dept of Urology, GRH and KMC,Chennai.